Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma

被引:45
作者
McCrea, Heather J. [1 ,2 ]
Bander, Evan D. [1 ]
Venn, Rachael A. [1 ]
Reiner, Anne S. [2 ,3 ]
Iorgulescu, J. Bryan [1 ]
Puchi, Luis A. [1 ]
Schaefer, Peter M. [1 ]
Cederquist, Gustav [1 ]
Greenfield, Jeffrey P. [1 ,2 ,4 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[4] Childrens Brain Tumor Project, New York, NY USA
关键词
Anaplastic astrocytoma; Brainstem glioma; Diffuse intrinsic pontine glioma; Glioblastoma; High-grade glioma; Pediatrics; BRAIN-STEM GLIOMA; MALIGNANT GLIOMAS; PEDIATRIC-PATIENTS; CHEMOTHERAPY; ASTROCYTOMA; CHILDHOOD; TUMORS; EPIDEMIOLOGY; TRIAL; GBM;
D O I
10.1227/NEU.0000000000000845
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
BACKGROUND:Survival duration and prognostic factors in adult high-grade glioma have been comprehensively analyzed, but less is known about factors contributing to overall survival (OS) and progression-free survival (PFS) in pediatric patients.OBJECTIVE:To identify these factors in the pediatric population.METHODS:We retrospectively reviewed institutional databases evaluating all patients 21 years with high-grade glioma treated between 1988 and 2010. Kaplan-Meier curves and log-rank statistics were used to compare groups univariately. Multivariate analyses were completed using Cox proportional hazards regression models.RESULTS:Ninety-seven patients were identified with a median age of 11 years. Median OS was 1.7 years, and median PFS was 272 days. Location was significant for OS (P < .001). Patients with gross total resection (GTR) had a median OS of 3.4 years vs 1.6 years for subtotal resection and 1.3 years for biopsy patients (P < .001). Female patients had improved OS (P = .01). Female patients with GTR had a mean OS of 8.1 years vs 2.4 years for male patients with GTR and 1.4 years for all other female patients and male patients (P = .001). PFS favored patients 3 and 13 years and females (P = .003 and .001).CONCLUSION:OS was significantly correlated with the location of the tumor and the extent of resection. GTR significantly improved overall survival for both glioblastoma multiforme and anaplastic astrocytoma patients, and female patients showed a much larger survival benefit from GTR than male patients.ABBREVIATIONS:AA, anaplastic astrocytomaGBM, glioblastoma multiformeGTR, gross total resectionHGG, high-grade gliomaOS, overall survivalPFS, progression-free survivalSTR, subtotal resectionWHO, World Health Organization
引用
收藏
页码:443 / 452
页数:10
相关论文
共 24 条
[1]
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium [J].
Bondy, Melissa L. ;
Scheurer, Michael E. ;
Malmer, Beatrice ;
Barnholtz-Sloan, Jill S. ;
Davis, Faith G. ;
Il'Yasova, Dora ;
Kruchko, Carol ;
McCarthy, Bridget J. ;
Rajaraman, Preetha ;
Schwartzbaum, Judith A. ;
Sadetzki, Siegal ;
Schlehofer, Brigitte ;
Tihan, Tarik ;
Wiemels, Joseph L. ;
Wrensch, Margaret ;
Buffler, Patricia A. .
CANCER, 2008, 113 (07) :1953-1968
[2]
Supratentorial high-grade astrocytoma and diffuse brainstem glioma: Two challenges for the pediatric oncologist [J].
Broniscer, A ;
Gajjar, A .
ONCOLOGIST, 2004, 9 (02) :197-206
[3]
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group [J].
Cohen, Kenneth J. ;
Pollack, Ian F. ;
Zhou, Tianni ;
Buxton, Allen ;
Holmes, Emiko J. ;
Burger, Peter C. ;
Brat, Daniel J. ;
Rosenblum, Marc K. ;
Hamilton, Ronald L. ;
Lavey, Robert S. ;
Heideman, Richard L. .
NEURO-ONCOLOGY, 2011, 13 (03) :317-323
[4]
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009 [J].
Dolecek, Therese A. ;
Propp, Jennifer M. ;
Stroup, Nancy E. ;
Kruchko, Carol .
NEURO-ONCOLOGY, 2012, 14 :v1-v49
[5]
POSTOPERATIVE CHEMOTHERAPY AND DELAYED RADIATION IN CHILDREN LESS-THAN 3 YEARS OF AGE WITH MALIGNANT BRAIN-TUMORS [J].
DUFFNER, PK ;
HOROWITZ, ME ;
KRISCHER, JP ;
FRIEDMAN, HS ;
BURGER, PC ;
COHEN, ME ;
SANFORD, RA ;
MULHERN, RK ;
JAMES, HE ;
FREEMAN, CR ;
SEIDEL, FG ;
KUN, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24) :1725-1731
[6]
Duffner PK, 1996, J NEURO-ONCOL, V28, P245
[7]
High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol [J].
Dufour, C. ;
Grill, J. ;
Lellouch-Tubiana, A. ;
Puget, S. ;
Chastagner, P. ;
Frappaz, D. ;
Doz, F. ;
Pichon, F. ;
Plantaz, D. ;
Gentet, J. C. ;
Raquin, M. A. ;
Kalifa, C. .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (17) :2939-2945
[8]
Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology [J].
Fangusaro, Jason .
FRONTIERS IN ONCOLOGY, 2012, 2
[9]
The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: A historical - and futuristic - perspective [J].
Finlay, JL ;
Zacharoulis, S .
JOURNAL OF NEURO-ONCOLOGY, 2005, 75 (03) :253-266
[10]
RANDOMIZED PHASE-III TRIAL IN CHILDHOOD HIGH-GRADE ASTROCYTOMA COMPARING VINCRISTINE, LOMUSTINE, AND PREDNISONE WITH THE 8-DRUGS-IN-1-DAY REGIMEN [J].
FINLAY, JL ;
BOYETT, JM ;
YATES, AJ ;
WISOFF, JH ;
MILSTEIN, JM ;
GEYER, JR ;
BERTOLONE, SJ ;
MCGUIRE, P ;
CHERLOW, JM ;
TEFFT, M ;
TURSKI, PA ;
WARA, WM ;
EDWARDS, M ;
SUTTON, LN ;
BERGER, MS ;
EPSTEIN, F ;
AYERS, G ;
ALLEN, JC ;
PACKER, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :112-123